Vanguard Capital Management’s Obsidian Therapeutics OBX Stock Holding History
Bought
Maintained
Sold
Other funds holding OBX
Vanguard Capital Management's OBX Position: Q3 2026 in Review
Vanguard Capital Management opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 2,441,332 shares worth $33.5M. The stake represents ﹤0.01% of the portfolio and ranks #2115 among its holdings.
61 funds tracked by Wall St. Rank hold OBX as of Q3 2026.
- Vanguard Capital Management held 2,441,332 shares of Obsidian Therapeutics worth $33.5M as of Q3 2026.
- Obsidian Therapeutics was a new Vanguard Capital Management position in Q3 2026.
- Obsidian Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2115 holding.
- 61 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.